Literature DB >> 29339238

Topical betaxolol for treating relapsing paronychia with pyogenic granuloma-like lesions induced by epidermal growth factor receptor inhibitors.

Chi-Feng Yen1, Chao-Kai Hsu2, Chun-Wei Lu3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29339238     DOI： 10.1016/j.jaad.2018.01.015

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  4 in total

Review 1.  Acute and Chronic Paronychia Revisited: A Narrative Review.

Authors:  Vineet Relhan; Anuva Bansal
Journal:  J Cutan Aesthet Surg       Date:  2022 Jan-Mar

Review 2.  Management of dermatologic adverse events from cancer therapies: recommendations of an expert panel.

Authors:  Jade Cury-Martins; Adriana Pessoa Mendes Eris; Cristina Martinez Zugaib Abdalla; Giselle de Barros Silva; Veronica Paula Torel de Moura; Jose Antonio Sanches
Journal:  An Bras Dermatol       Date:  2020-02-15       Impact factor: 1.896

Review 3.  Efficacy of topical beta-blockers in the management of EGFR-inhibitor induced paronychia and pyogenic granuloma-like lesions: case series and review of the literature.

Authors:  Pietro Sollena; Maria Mannino; Francesco Tassone; Maria Alessandra Calegari; Ettore D'Argento; Ketty Peris
Journal:  Drugs Context       Date:  2019-11-06

Review 4.  Topical beta-blockers in dermatologic therapy.

Authors:  Angela Filoni; Francesca Ambrogio; Aurora De Marco; Alessia Pacifico; Domenico Bonamonte
Journal:  Dermatol Ther       Date:  2021-06-21       Impact factor: 2.851
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.